Zoetis
Trade Zoetis 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ZTS
Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. It operates through the United States and International geographical segments.
ZTS Key Statistics
Stock Snapshot
Zoetis(ZTS) stock is priced at $77.70, giving the company a market capitalization of 32.04B. It carries a P/E multiple of 12.71 and pays a dividend yield of 2.70%.
On 2026-08-26, Zoetis(ZTS) stock traded between a low of $76.62 and a high of $78.75. Shares are currently priced at $77.70, which is +1.4% above the low and -1.3% below the high.
The Zoetis(ZTS)'s current trading volume is 4.85M, compared to an average daily volume of 4.9M.
In the last year, Zoetis(ZTS) shares hit a 52-week high of $156.49 and a 52-week low of $71.00.
In the last year, Zoetis(ZTS) shares hit a 52-week high of $156.49 and a 52-week low of $71.00.
ZTS News
On 13 August 2026, Zoetis Inc. announced that its Simparica Trio chewable received U.S. FDA Emergency Use Authorization to treat life-threatening New World scre...
TD Cowen analyst Steve Scala lowered the firm’s price target on Zoetis (ZTS) to $94 from $104 and keeps a Buy rating on the shares. The firm reduced their near-...